Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anaptysbio, Inc (ANAB) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Anaptysbio, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1370053.
Total stock buying since 2017: $121,507,341.
Total stock sales since 2017: $72,146,477.
Total stock option exercises since 2017: $2,906,204.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 37,186 | $835,575 | 160,074 | $493,005 |
| 2024 | 273,972 | $9,999,978 | 228,250 | $5,823,429 | 125,154 | $572,900 |
| 2023 | 0 | $0 | 14,987 | $285,996 | 18,000 | $0 |
| 2022 | 668,237 | $14,453,966 | 672,406 | $14,550,534 | 2,500 | $35,050 |
| 2021 | 3,707,100 | $72,002,827 | 124,645 | $4,218,808 | 134,645 | $359,651 |
| 2020 | 0 | $0 | 0 | $0 | 20,000 | $22,400 |
| 2019 | 3,600 | $50,580 | 91,563 | $6,576,902 | 135,337 | $526,610 |
| 2018 | 0 | $0 | 207,361 | $15,196,251 | 358,767 | $896,588 |
| 2017 | 1,666,666 | $24,999,990 | 1,133,940 | $24,658,982 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 10,231 | $200,200 | 10,231 | $70,900 |
| 2025-07 | 0 | $0 | 20,925 | $490,837 | 20,925 | $145,010 |
| 2025-06 | 0 | $0 | 6,030 | $144,538 | 43,510 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 85,408 | $277,095 |
| 2024-11 | 0 | $0 | 10,000 | $250,000 | 10,000 | $69,300 |
| 2024-09 | 0 | $0 | 28,440 | $1,117,375 | 35,800 | $299,450 |
| 2024-08 | 273,972 | $9,999,978 | 2,000 | $80,000 | 2,000 | $37,000 |
| 2024-07 | 0 | $0 | 11,500 | $359,930 | 11,500 | $97,050 |
| 2024-06 | 0 | $0 | 3,900 | $90,343 | 26,069 | $0 |
| 2024-05 | 0 | $0 | 1,500 | $35,580 | 0 | $0 |
| 2024-03 | 0 | $0 | 148,940 | $3,389,510 | 0 | $0 |
| 2024-02 | 0 | $0 | 5,000 | $125,000 | 5,000 | $70,100 |
| 2024-01 | 0 | $0 | 16,970 | $375,691 | 34,785 | $0 |
| 2023-11 | 0 | $0 | 882 | $12,515 | 0 | $0 |
| 2023-09 | 0 | $0 | 14,105 | $273,481 | 18,000 | $0 |
| 2022-08 | 0 | $0 | 523 | $13,075 | 0 | $0 |
| 2022-06 | 0 | $0 | 2,500 | $60,000 | 2,500 | $35,050 |
| 2022-05 | 668,237 | $14,453,966 | 669,383 | $14,477,459 | 0 | $0 |
| 2021-12 | 0 | $0 | 36,645 | $1,307,640 | 36,645 | $41,042 |
| 2021-11 | 0 | $0 | 62,007 | $2,081,378 | 62,007 | $149,297 |
| 2021-10 | 0 | $0 | 15,993 | $479,790 | 15,993 | $17,912 |
| 2021-09 | 0 | $0 | 0 | $0 | 10,000 | $11,200 |
| 2021-05 | 185,800 | $4,320,623 | 0 | $0 | 0 | $0 |
| 2021-04 | 183,000 | $4,307,040 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-08 | Renton Hollings | Sale | 10,231 | 19.57 | 200,200 |
| 2025-08-08 | Renton Hollings | Option Ex | 10,231 | 6.93 | 70,900 |
| 2025-07-02 | Renton Hollings | Sale | 20,925 | 23.46 | 490,837 |
| 2025-07-02 | Renton Hollings | Option Ex | 20,925 | 6.93 | 145,010 |
| 2025-06-18 | Renton Hollings | Sale | 3,015 | 23.97 | 72,269 |
| 2025-06-18 | Fenton Dennis M | Sale | 3,015 | 23.97 | 72,269 |
| 2025-06-15 | Ware J. Anthony | Option Ex | 6,030 | .00 | 0 |
| 2025-06-15 | Jain Rita | Option Ex | 7,330 | .00 | 0 |
| 2025-06-15 | Marquet Magda | Option Ex | 6,030 | .00 | 0 |
| 2025-06-15 | Schmid John P. | Option Ex | 6,030 | .00 | 0 |
| 2025-06-15 | Orwin John A | Option Ex | 6,030 | .00 | 0 |
| 2025-06-15 | Renton Hollings | Option Ex | 6,030 | .00 | 0 |
| 2025-06-15 | Fenton Dennis M | Option Ex | 6,030 | .00 | 0 |
| 2025-01-13 | Schmid John P. | Option Ex | 42,337 | 6.54 | 277,095 |
| 2025-01-06 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 6,145 | .00 | 0 |
| 2025-01-06 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Option Ex | 5,245 | .00 | 0 |
| 2025-01-06 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Option Ex | 5,545 | .00 | 0 |
| 2025-01-03 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 10,555 | .00 | 0 |
| 2025-01-03 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Option Ex | 8,293 | .00 | 0 |
| 2025-01-03 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Option Ex | 7,288 | .00 | 0 |
| 2024-11-29 | Renton Hollings | Sale | 10,000 | 25.00 | 250,000 |
| 2024-11-29 | Renton Hollings | Option Ex | 10,000 | 6.93 | 69,300 |
| 2024-09-23 | Lizzul Paul F. (Chief Medical Officer) | Sale | 1,500 | 38.67 | 58,005 |
| 2024-09-23 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 1,500 | 18.50 | 27,750 |
| 2024-09-17 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Sale | 3,780 | 38.41 | 145,189 |
| 2024-09-16 | Lizzul Paul F. (Chief Medical Officer) | Sale | 2,220 | 38.93 | 86,424 |
| 2024-09-16 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Sale | 12,220 | 39.53 | 483,056 |
| 2024-09-16 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Option Ex | 10,000 | 20.16 | 201,600 |
| 2024-09-16 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Sale | 8,720 | 39.53 | 344,701 |
| 2024-09-16 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Option Ex | 5,000 | 14.02 | 70,100 |
| 2024-09-15 | Orwin John A | Option Ex | 1,300 | .00 | 0 |
| 2024-09-14 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 6,000 | .00 | 0 |
| 2024-09-14 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Option Ex | 6,000 | .00 | 0 |
| 2024-09-14 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Option Ex | 6,000 | .00 | 0 |
| 2024-08-14 | Lizzul Paul F. (Chief Medical Officer) | Sale | 2,000 | 40.00 | 80,000 |
| 2024-08-14 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 2,000 | 18.50 | 37,000 |
| 2024-08-14 | Ecor1 Capital, Llc | Buy | 273,972 | 36.50 | 9,999,978 |
| 2024-07-18 | Lizzul Paul F. (Chief Medical Officer) | Sale | 1,500 | 35.00 | 52,500 |
| 2024-07-18 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 1,500 | 18.50 | 27,750 |
| 2024-07-15 | Renton Hollings | Sale | 10,000 | 30.74 | 307,430 |
| 2024-07-15 | Renton Hollings | Option Ex | 10,000 | 6.93 | 69,300 |
| 2024-06-21 | Fenton Dennis M | Sale | 1,950 | 23.17 | 45,181 |
| 2024-06-18 | Renton Hollings | Sale | 1,950 | 23.16 | 45,162 |
| 2024-06-15 | Ware J. Anthony | Option Ex | 3,900 | .00 | 0 |
| 2024-06-15 | Jain Rita | Option Ex | 4,534 | .00 | 0 |
| 2024-06-15 | Marquet Magda | Option Ex | 3,900 | .00 | 0 |
| 2024-06-15 | Schmid John P. | Option Ex | 3,900 | .00 | 0 |
| 2024-06-15 | Orwin John A | Option Ex | 2,035 | .00 | 0 |
| 2024-06-15 | Renton Hollings | Option Ex | 3,900 | .00 | 0 |
| 2024-06-15 | Fenton Dennis M | Option Ex | 3,900 | .00 | 0 |
| 2024-05-22 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Sale | 1,500 | 23.72 | 35,580 |
| 2024-03-25 | Faga Daniel (CEO) | Sale | 3,000 | 21.42 | 64,268 |
| 2024-03-22 | Faga Daniel (CEO) | Sale | 145,940 | 22.79 | 3,325,242 |
| 2024-02-16 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Sale | 5,000 | 25.00 | 125,000 |
| 2024-02-16 | Loumeau Eric J (CHIEF LEGAL OFFICER) | Option Ex | 5,000 | 14.02 | 70,100 |
| 2024-01-30 | Mulroy Dennis (CHIEF FINANCIAL OFFICER) | Sale | 3,065 | 23.63 | 72,425 |
| 2024-01-08 | Lizzul Paul F. (Chief Medical Officer) | Sale | 2,554 | 21.81 | 55,702 |
| 2024-01-08 | Faga Daniel (CEO) | Sale | 6,866 | 21.81 | 149,747 |
| 2024-01-08 | Mulroy Dennis (Chief Financial Officer) | Sale | 2,180 | 21.81 | 47,545 |
| 2024-01-08 | Loumeau Eric J (Chief Legal Officer) | Sale | 2,305 | 21.81 | 50,272 |
| 2024-01-06 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 6,145 | .00 | 0 |
| 2024-01-06 | Faga Daniel (CEO) | Option Ex | 17,850 | .00 | 0 |
| 2024-01-06 | Mulroy Dennis (Chief Financial Officer) | Option Ex | 5,245 | .00 | 0 |
| 2024-01-06 | Loumeau Eric J (Chief Legal Officer) | Option Ex | 5,545 | .00 | 0 |
| 2023-11-22 | Loumeau Eric J (Chief Legal Officer) | Sale | 882 | 14.19 | 12,515 |
| 2023-09-18 | Mulroy Dennis (Chief Financial Officer) | Sale | 3,895 | 19.32 | 75,235 |
| 2023-09-18 | Loumeau Eric J (Chief Legal Officer) | Sale | 3,895 | 19.32 | 75,231 |
| 2023-09-14 | Lizzul Paul F. (Chief Medical Officer) | Sale | 2,105 | 19.48 | 41,005 |
| 2023-09-14 | Lizzul Paul F. (Chief Medical Officer) | Option Ex | 6,000 | .00 | 0 |
| 2023-09-14 | Mulroy Dennis (Chief Financial Officer) | Sale | 2,105 | 19.48 | 41,005 |
| 2023-09-14 | Mulroy Dennis (Chief Financial Officer) | Option Ex | 6,000 | .00 | 0 |
| 2023-09-14 | Loumeau Eric J (Chief Legal Officer) | Sale | 2,105 | 19.48 | 41,005 |
| 2023-09-14 | Loumeau Eric J (Chief Legal Officer) | Option Ex | 6,000 | .00 | 0 |
| 2022-08-08 | Loumeau Eric J (COO, General Counsel) | Sale | 523 | 25.00 | 13,075 |
| 2022-06-08 | Loumeau Eric J (COO, General Counsel) | Sale | 2,500 | 24.00 | 60,000 |
| 2022-06-08 | Loumeau Eric J (COO, General Counsel) | Option Ex | 2,500 | 14.02 | 35,050 |
| 2022-05-18 | Loumeau Eric J (COO, General Counsel) | Sale | 1,146 | 20.50 | 23,493 |
| 2022-05-05 | Nodelman Oleg | Buy | 668,237 | 21.63 | 14,453,966 |
| 2022-05-05 | Nodelman Oleg | Sale | 668,237 | 21.63 | 14,453,966 |
| 2021-12-20 | Suria Hamza (President, CEO) | Sale | 36,645 | 35.68 | 1,307,640 |
| 2021-12-20 | Suria Hamza (President, CEO) | Option Ex | 36,645 | 1.12 | 41,042 |
| 2021-11-05 | Suria Hamza (President, CEO) | Sale | 14,302 | 35.00 | 500,570 |
| 2021-11-05 | Suria Hamza (President, CEO) | Option Ex | 14,302 | 1.12 | 16,018 |
| 2021-11-04 | Suria Hamza (President, CEO) | Sale | 6,059 | 35.00 | 212,065 |
| 2021-11-04 | Suria Hamza (President, CEO) | Option Ex | 6,059 | 1.12 | 6,786 |
| 2021-11-04 | Loumeau Eric J (COO, General Counsel) | Sale | 5,000 | 35.00 | 175,000 |
| 2021-11-04 | Loumeau Eric J (COO, General Counsel) | Option Ex | 5,000 | 17.09 | 85,450 |
| 2021-11-01 | Suria Hamza (President, CEO) | Sale | 36,646 | 32.58 | 1,193,743 |
| 2021-11-01 | Suria Hamza (President, CEO) | Option Ex | 36,646 | 1.12 | 41,043 |
| 2021-10-26 | Suria Hamza (President, CEO) | Sale | 15,993 | 30.00 | 479,790 |
| 2021-10-26 | Suria Hamza (President, CEO) | Option Ex | 15,993 | 1.12 | 17,912 |
| 2021-09-17 | Suria Hamza (President, CEO) | Option Ex | 10,000 | 1.12 | 11,200 |
| 2021-05-04 | Nodelman Oleg | Buy | 165,000 | 23.25 | 3,835,755 |
| 2021-05-03 | Nodelman Oleg | Buy | 20,800 | 23.31 | 484,868 |
| 2021-04-30 | Nodelman Oleg | Buy | 35,700 | 23.16 | 826,812 |
| 2021-04-27 | Nodelman Oleg | Buy | 33,800 | 23.82 | 805,082 |
| 2021-04-26 | Nodelman Oleg | Buy | 13,900 | 23.80 | 330,861 |
| 2021-04-23 | Nodelman Oleg | Buy | 99,600 | 23.54 | 2,344,285 |
| 2021-03-09 | Ecor1 Capital, Llc | Buy | 531,000 | 18.70 | 9,928,638 |
| 2021-03-08 | Ecor1 Capital, Llc | Buy | 2,777,800 | 18.97 | 52,694,866 |
| 2021-02-23 | Ecor1 Capital, Llc | Buy | 29,500 | 25.48 | 751,660 |
| 2021-02-12 | Loumeau Eric J (COO, General Counsel) | Sale | 10,000 | 35.00 | 350,000 |
| 2021-02-12 | Loumeau Eric J (COO, General Counsel) | Option Ex | 10,000 | 14.02 | 140,200 |
| 2020-03-10 | Suria Hamza (President, CEO) | Option Ex | 10,000 | 1.12 | 11,200 |
| 2020-02-05 | Suria Hamza (President, CEO) | Option Ex | 10,000 | 1.12 | 11,200 |
| 2019-12-10 | Ware J. Anthony (Director) | Buy | 3,600 | 14.05 | 50,580 |
| 2019-11-27 | Londei Marco (Chief Medical Officer) | Option Ex | 46,202 | 6.93 | 320,179 |
| 2019-11-22 | Suria Hamza (President, CEO) | Option Ex | 10,000 | 1.12 | 11,200 |
| 2019-06-10 | Suria Hamza (President, CEO) | Sale | 22,428 | 74.64 | 1,674,025 |
| 2019-06-04 | Londei Marco (Chief Medical Officer) | Sale | 10,060 | 73.46 | 738,997 |
| 2019-06-04 | Londei Marco (Chief Medical Officer) | Option Ex | 10,060 | .70 | 7,042 |
| 2019-04-17 | Suria Hamza (President, CEO) | Option Ex | 10,000 | 1.12 | 11,200 |
| 2019-01-15 | Londei Marco (Chief Medical Officer) | Sale | 19,075 | 69.66 | 1,328,840 |
| 2019-01-15 | Londei Marco (Chief Medical Officer) | Option Ex | 19,075 | 6.93 | 132,189 |
| 2019-01-14 | Suria Hamza (President, CEO) | Sale | 40,000 | 70.88 | 2,835,040 |
| 2019-01-14 | Suria Hamza (President, CEO) | Option Ex | 40,000 | 1.12 | 44,800 |
| 2018-12-17 | Londei Marco (Chief Medical Officer) | Sale | 30,048 | 66.94 | 2,011,563 |
| 2018-12-17 | Londei Marco (Chief Medical Officer) | Option Ex | 30,048 | 3.81 | 114,633 |
| 2018-12-14 | Suria Hamza (President, CEO) | Sale | 41,728 | 69.69 | 2,908,107 |
| 2018-12-14 | Suria Hamza (President, CEO) | Option Ex | 41,728 | 1.12 | 46,735 |
| 2018-12-12 | Suria Hamza (President, CEO) | Sale | 30,000 | 71.97 | 2,159,040 |
| 2018-12-12 | Suria Hamza (President, CEO) | Option Ex | 30,000 | 1.12 | 33,600 |
| 2018-12-11 | Suria Hamza (President, CEO) | Sale | 4,998 | 70.83 | 354,008 |
| 2018-12-10 | Suria Hamza (President, CEO) | Sale | 30,587 | 71.52 | 2,187,429 |
| 2018-12-10 | Suria Hamza (President, CEO) | Option Ex | 30,587 | 1.12 | 34,257 |
| 2018-12-03 | Piscitelli Dominic (Chief Financial Officer) | Sale | 37,000 | 72.87 | 2,696,227 |
| 2018-12-03 | Piscitelli Dominic (Chief Financial Officer) | Option Ex | 37,000 | 11.34 | 419,580 |
| 2018-09-07 | Londei Marco (Chief Medical Officer) | Option Ex | 142,857 | .70 | 99,999 |
| 2018-07-09 | Suria Hamza (President, CEO) | Option Ex | 7,636 | 1.93 | 14,699 |
| 2018-06-08 | Suria Hamza (President, CEO) | Option Ex | 22,428 | 2.59 | 58,088 |
| 2018-04-16 | Lydon Nicholas (Director) | Sale | 33,000 | 87.27 | 2,879,877 |
| 2018-02-15 | Lydon Nicholas (Director) | Option Ex | 16,483 | 4.55 | 74,997 |
| 2017-08-21 | Novo Holdings A/s (10% Owner) | Sale | 356,300 | 21.10 | 7,518,286 |
| 2017-08-15 | Novo Holdings A/s (10% Owner) | Sale | 143,428 | 21.00 | 3,011,988 |
| 2017-08-14 | Novo Holdings A/s (10% Owner) | Sale | 35,172 | 21.79 | 766,503 |
| 2017-08-07 | Novo Holdings A/s (10% Owner) | Sale | 481,023 | 22.01 | 10,586,354 |
| 2017-08-04 | Novo Holdings A/s (10% Owner) | Sale | 10,271 | 22.00 | 225,962 |
| 2017-08-03 | Novo Holdings A/s (10% Owner) | Sale | 21,451 | 22.01 | 472,200 |
| 2017-08-02 | Novo Holdings A/s (10% Owner) | Sale | 25,700 | 23.87 | 613,484 |
| 2017-08-01 | Novo Holdings A/s (10% Owner) | Sale | 23,555 | 23.87 | 562,281 |
| 2017-07-26 | Tomlin Stephen Lawrence (Other) | Sale | 37,040 | 24.35 | 901,924 |
| 2017-01-31 | Lydon Nicholas (Director) | Buy | 16,666 | 15.00 | 249,990 |
| 2017-01-31 | Novo A/s (10% Owner) | Buy | 50,000 | 15.00 | 750,000 |
| 2017-01-31 | Heron Patrick J (10% Owner) | Buy | 800,000 | 15.00 | 12,000,000 |
| 2017-01-31 | Topper James N (Director) | Buy | 400,000 | 15.00 | 6,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ANAB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Anaptysbio, Inc (symbol ANAB, CIK number 1370053) see the Securities and Exchange Commission (SEC) website.